GHK-Cu side effects

GHK-Cu side effects are the mildest of any peptide on this site. The molecule is naturally produced by the human body, has been in cosmetic dermatology use for decades, and has an extensive safety record both topically and at typical injectable doses. That doesn't make it risk-free — there are specific contraindications and considerations to understand — but the baseline is unusually clean.

The short answer

Topical side effects

Topical GHK-Cu has been in cosmetic use for decades. The reported side-effect profile is mild:

• Mild skin irritation — occasional, especially in the first week of use. Usually resolves on its own.
• Localized redness or itching — uncommon; suggests sensitivity to the formulation rather than to GHK-Cu specifically.
• Allergic contact dermatitis — rare. If skin reaction persists or worsens, discontinue.
• Interaction with high-concentration vitamin C — not a side effect per se, but the chemistry can be disrupted; split application across AM and PM.

For sensitive skin, start with a lower concentration (0.05–0.5%) and lower frequency (once daily) before scaling up.

Injectable side effects

Injectable GHK-Cu is less well-characterized than topical, but the reported profile is still mild compared to most peptides:

Common (and mostly cosmetic)

• Bluish injection-site discoloration — the copper ion can stain local tissue, leaving a transient blue or grey-blue mark around the injection site. Harmless. Resolves in days.
• Mild redness or swelling at injection site — typical SubQ reaction, not specific to GHK-Cu.
• Mild stinging during injection — copper-containing solutions can sting slightly more than other peptides.

Less common

• Headache — occasional, usually with higher doses (2+ mg).
• Mild nausea or GI discomfort — uncommon, usually dose-dependent.
• Fatigue or sluggishness — uncommon, transient.
• Metallic taste — rare, transient.

Theoretical concerns

• Copper accumulation — at typical doses (1–2 mg, 2–3x weekly), the actual copper load is small and well below dietary copper intake. At sustained high doses (3+ mg daily for months), the theoretical load increases. Not documented as a clinical problem at typical strength-community doses, but worth flagging for chronic high-dose use.
• Liver enzyme changes — long-term safety data is thin; baseline and follow-up labs are reasonable for users on chronic injectable protocols.

Contraindications

These are the situations where GHK-Cu should not be used:

• Wilson's disease — a genetic disorder of copper metabolism. Adding exogenous copper-bound peptide is contraindicated.
• Active copper toxicity — for any reason
• Severe copper sensitivity or known copper allergy
• Pregnancy and breastfeeding — no safety data; default to avoid
• Active malignancy — GHK-Cu's tissue-remodeling and pro-angiogenic effects are theoretically a concern in active cancer; defer to oncology team

Drug interactions

GHK-Cu has minimal documented drug interactions. Considerations:

• Copper chelators (penicillamine, trientine) — used in Wilson's disease; GHK-Cu directly opposes their mechanism
• Zinc supplements at high doses — zinc and copper compete for absorption; not directly a GHK-Cu issue but worth noting in a stack
• High-concentration vitamin C in the same skincare application — disrupts the copper-peptide complex; split across AM and PM
• Other peptides in a stack — no known conflicts with BPC-157, TB-500, GH secretagogues, IGF-1 LR3, or MOTS-C

Comparison with other strength peptides

GHK-Cu is the most benign of the group at typical doses.

When to stop

Discontinue GHK-Cu and consult a clinician if you experience:

• Persistent or worsening skin reaction (topical) lasting more than a week after starting
• Allergic reaction signs — significant swelling, hives, breathing difficulty
• Persistent injection-site reactions beyond mild local redness
• New symptoms suggesting copper toxicity (rare): nausea, abdominal pain, neurological changes
• Any unexplained liver-related symptoms during chronic injectable use

Quality matters

Some "side effects" reported on internet forums are likely vendor-quality issues, not GHK-Cu effects. A poorly synthesized or contaminated batch can produce reactions that have nothing to do with the peptide itself. See vendor quality checks. Cosmetic-grade topical products from established skincare brands have substantially better quality control than research-chem injectables.

Related reading

• GHK-Cu protocol
• GHK-Cu research evidence
• GHK-Cu storage and stability
• Side effects overview